Neonatal diethylstilbestrol treatment alters the estrogen-regulated expression of both cell proliferation and apoptosis-related proto-oncogenes (c-jun, c-fos, c-myc, bax, bcl-2, and bcl-x) in the hamster uterus

Cell Growth and Differentiation

Volumn 8, Issue 4, 1997, Pages 425-434

  Zheng, Xinglong ^a,b   Hendry III, William J ^a  

^a WICHITA STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; MESSENGER RNA; ONCOPROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOMETRIUM CELL; FEMALE; GENE EXPRESSION; NONHUMAN; ONCOGENE C FOS; ONCOGENE C JUN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; SYRIAN HAMSTER; UTERUS;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, NORTHERN; CELL DIVISION; CRICETINAE; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; FEMALE; MESOCRICETUS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; UTERUS;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 0030980751     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (94)

1. Kuchera, L. K. Postcoital contraception with diethylstilbestrol-updated. Contraception, 10: 47-54, 1974.
2. Herbst, A. L., Scully, R. E., and Robboy, S. J. Prenatal diethylstilbestrol exposure and human genital tract abnormalities. Monogr. Natl. Cancer Inst., 51: 25-35, 1979.
3. Herbst, A. L., Ulfelder, H., and Poskanzer, D. C. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N. Engl. J. Med., 284: 878-881, 1971.
4. Herbst, A. L., and Anderson, D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin. Surg. Oncol., 6: 343-346, 1990.
5. Marselos, M., and Tomatis, L. Diethylstilbestrol. I. Pharmacology, toxicology and carcinogenicity in humans. Eur. J. Cancer, 28A: 1182-1189, 1992.
6. Forsberg, J-G. Cervicovaginal epithelium: its origin and development. Am. J. Obstet. Gynecol., 115: 1025-1043, 1973.
7. McLachlan, J. A. Transplacental effects of diethylstilbestrol in mice. Monogr. Natl. Cancer Inst., 51: 67-72, 1979.
8. Forsberg, J-G., and Kalland, T. Neonatal estrogen treatment and epithelial abnormalities in the cervicovaginal epithelium of adult mice. Cancer Res., 41: 721-734, 1981.
9. Halling, A., and Forsberg, J-G. Acute and permanent growth effects in the mouse uterus after neonatal treatment with estrogens. Reprod. Toxicol., 7: 137-153, 1993.
10. Sheehan, D. M., Branham, W. S., Medlock, K. L., Olson, M. E., and Zehr, D. R. Uterine responses to estradiol in the neonatal rat. Endocrinology, 109: 76-82, 1981.
11. Branham, W. S., Zehr, D. R., Chen, J. J., and Sheehan, D. M. Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology, 51: 201-212, 1988.
12. Newbold, R. R., Bullock, B. C., and McLachlan, J. A. Diverticulosis and salpingitis isthmica nodosa (SIN) of the fallopian tube. Am. J. Pathol., 117: 333-335, 1984.
13. Medlock, K. L., Branham, W. S., and Sheehan, D. M. Long-term effects of postnatal exposure to diethylstilbestrol on uterine estrogen receptor and growth. J. Steroid Biochem. Mol. Biol., 42: 23-28, 1992.
14. Leavitt, W. W., Evans, R. W., and Hendry, W. J. Etiology of DES-induced uterine tumors in the Syrian hamster. In: W. W. Leavitt (ed.), Hormones and Cancer, pp. 63-86. New York: Plenum Publishing Corp., 1982.
15. Hendry, W. J., and Leavitt, W. W. Altered morphogenesis of the immature hamster uterus following neonatal exposure to diethylstilbestrol. Differentiation, 52: 221-227, 1993.
16. Rustia, M., and Shubik, P. Transplacental effects of diethylstilbestrol on the genital tract of hamster offspring. Cancer Lett., 1: 139-146, 1976.
17. Leavitt, W. W., Evans, R. W., Hendry, W. J., and Williams, K. I. H. Antioestrogen and progestin action in diethylstilbestrol-induced endometrial abnormalities in the Syrian hamster. In: R. L. Sutherland and V. C. Jordan (eds.), Non-Steroid Antioestrogens: Subcellular Phamacology and Antitumor Activity, pp. 167-176. Sydney, Australia: Academic Press, 1981.
18. DiAugustine, R. P., Petruez, P., Bell, G. I., Brown, C. F., Korach, K. S., McLachlan, J. A., and Teng, C. T. Influences of estrogens on mouse uterine epidermal growth factor precursor protein and messenger ribonucleic acid. Endocrinology, 122: 2355-2363, 1988.
19. Gardner, R. M., Verner, G., Kirkland, J. L., and Stancel, G. M. Regulation of uterine epidermal growth factor (EGF) receptors by estrogen in the mature rat and during the estrous cycle. J. Steroid Biochem., 32: 339-343, 1989.
20. Murphy, L. J., and Ghahary, A. Uterine insulin-like growth factor: regulation of expression and its role in estrogen-induced uterine proliferation. Endocr. Rev., 11: 443-453, 1990.
21. Nelson, K. G., Sakai, Y., Eitzman, B., Steed, T., and McLachlan, J. Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth & Differ., 5: 595-606, 1994.
22. Weisz, A., Cicatiello, L., Persico, E., Scaloma, M., and Bresciani, F. Estrogen stimulates transcription of c-jun protooncogene. Mol. Endocrinol., 4: 1041-1050, 1990.
23. Chiappetta, C., Kirkland, J. L., Loose-Mitchell, D. S., Murthy, L., and Stancel, G. M. Estrogen regulates expression of the jun family of protooncogenes in the uterus. J. Steroid Biochem. Mol. Biol., 41: 113-123, 1992.
24. Loose-Mitchell, D. S., Chiappetta, C., and Stancel, G. M. Estrogen regulation of c-fos messenger ribonucleic acid. Mol. Endocrinol., 2: 946-951, 1988.
25. Jouvenot, M., Pellerin, I., Alkhalaf, M., Marechal, G., Royez, M., and Adessi, G. L. Effects of 17 β-estradiol and growth factors on c-fos gene expression in endometrial epithelial cells in primary culture. Mol. Cell. Endocrinol., 72: 149-157, 1990.
26. Lau, L. F., and Nathans, D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc. Proc. Natl. Acad. Sci. USA, 84: 1182-1186, 1987.
27. Luscher, B., and Eisenman, R. N. New light on Myc and Myb. 1. Myc. Genes Dev. 4: 2025-2035, 1990.
28. Webb, D. K., Moulton, B. C., and Khan, S. A. Estrogen induced expression of the c-jun proto-oncogene in the immature and mature rat uterus. Biochem. Biophys. Res. Commun., 168: 721-726, 1990.
29. Weisz, A., and Bresciani, F. Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol. Endocrinol., 2: 816-824, 1988.
30. Williams, G. T., and Smith, C. A. Molecular regulation of apoptosis: genetic controls on cell death. Cell, 74: 777-779, 1993.
31. Hermeking, H., and Eick, D. Mediation of c-Myc-induced apoptosis by p53. Science (Washington DC), 265: 2091-2093, 1994.
32. Colotta, F., Polentarutti, N., Sironi, M., and Mantovani, A. Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines. J. Biol. Chem., 267: 18278-18283, 1992.
33. Bissonnette, R. P., Echeverri, F., Mahboubi, A., and Green, D. R. Apoptotic death induced by c-myc is inhibited by bcl-2. Nature (Lond.), 359: 552-555, 1992.
34. Evan, G. L., Wylie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
35. Askew, D. S., Ashmun, R. A., Simmons, B. C., and Cleveland, J. L. Constitutive c-myc expression in an IL-3 dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene, 6: 1915-1922, 1991.
36. Askew, D. S., Ihle, J. N., and Cleveland, J. L. Activation of apoptosis associated with enforced Myc expression in myeloid progenitor cells is dominant to the suppression of apoptosis by interleukin-3 or erythropoietin. Blood, 82: 2079-2087, 1993.
37. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Washington DC), 257: 212-214, 1992.
38. Gewirtz, D. A. DNA damage, gene expression, growth arrest and cell death. Oncol. Res., 5: 397-408, 1993.
39. Ueda, N., and Shah, S. V. Apoptosis. J. Lab. Clin. Med. 124: 169-177, 1994.
40. Tsujimoto, Y., Cossman, J., Jaffe, E., and Crose, C. H. Involvement of the bcl-2 oncogene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
41. Hockenbery, D. M., Zutter, M., Hichey, W., Nahm, M., and Korsmeyer, S. J. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA, 88: 6961-6965, 1991.
42. Monaghan, P., Robertson, D., Amos, A. S., Dyer, M. J. S., Mason, D. Y., and Greaves, M. F. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem., 40: 1819-1825, 1992.
43. Jacobson, M. D., Burne, J. F., King, M. P., Miyashita, T., Reed, J. C., and Raff, M. C. Apoptosis and bcl-2 protein in cells without mitochondrial DNA. Nature (Lond.), 367: 365-368, 1993.
44. Krajewski, S., Tanaka, S., Takayama, S., Schibler, M. J., Fenton, W., and Reed, J. C. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membrane. Cancer Res., 53: 4701-4714, 1993.
45. Tilly, J. L., Tilly, K. I., Kenton, M. L., and Johnson, A. L. Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-x long messenger ribonucleic acid levels. Endocrinology, 136: 232-241, 1995.
46. Lebrun, D. P., Warnke, R. A., and Cleary, M. L. Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am. J. Pathol., 142: 743-753, 1993.
47. Gompel, A., Sabourin, J. C., Martin, A., Yaneva, H., Audouin, J., Decroix, Y., and Poitout, P. Bcl-2 expression in normal endometrium during the menstrual cycle. Am. J. Pathol., 144: 1195-1202, 1994.
48. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haematopoietic cell survival and cooperates with c-myc to immortalize pre-B-cells. Nature (Lond.), 335: 440-442, 1988.
49. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., and Thompson, C. B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74: 597-608, 1993.
50. L is the major bcl-x mRNA form expressed during murine development and its product localizes to the mitochondria. Development, 120: 3033-3042, 1994.
51. Veis, D. J., Sorenson, C. M., Shutter, J. R., and Korsmeyer, S. J. Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell, 75: 229-240, 1993.
52. Nakayama, K-i., Nakayama, K., Negishi, I., Kuida, K., Shinkai, Y., Louie, M. C., Fields, L. E., Lucas, P. J., Stewart, V., Alt, F. W., and Loh, D. Y. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science (Washington DC), 267: 1584-1588, 1993.
53. Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K-i., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., and Loh, D. Y. Massive cell death of immature hematopoietic cells and neurons in bcl-x-deficient mice. Science (Washington DC), 267: 1506-1510, 1995.
54. Oltvai, Z., Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
55. Tilly, J. L. Use of the terminal transferase DNA labeling reaction for the biochemical and in situ analysis of apoptosis. In: J. E. Celis (ed.), Cell Biology: A Laboratory Handbook, pp. 330-337. Orlando, FL: Academic Press, 1994.
56. L and Bcl-2 displaces Bax and promotes cell death. Cell, 80: 285-291, 1995.
57. Vogt, P. K., and Bos, T. J. jun: oncogene and transcription factor. Adv. Cancer Res., 55: 1-35, 1990.
58. Distel, R. J., and Spiegelman, B. M. Protooncogene c-fos as a transcription factor. Adv. Cancer Res., 55: 37-55, 1990.
59. Koskinen, P. J., and Alitalo, K. Role of myc amplification and overexpression in cell growth, differentiation and death. Semin. Cancer Biol., 4: 3-12, 1993.
60. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
61. Dang, C. V. c-Myc oncoprotein function. Biochim. Biophys. Acta, 1072: 103-113, 1991.
62. Grosso, L. E., and Pitot, H. C. Modulation of c-myc expression in the HL-60 cell line. Biochem. Biophys. Res. Commun., 119: 473-480, 1984.
63. Travers, M. T., and Knowler, J. T. Oestrogen-induced expression of oncogenes in the immature rat uterus. FEBS Lett., 221: 27-30, 1987.
64. Hyder, S. M., Chiappetta, C., Kirkland, J. L., Lin, T-H., Loose-Mitchell, D. S., Murthy, L., Orengo, C. A., Tipnis, U., and Stancel, G. M. Estrogen regulation of protooncogene expression. In: J. J. Li, S. Nandi, and S. A. Li (eds.), Hormonal Carcinogenesis: Proceedings of the First International Symposium on Hormonal Carcinogenesis, Cancun, Mexico, pp. 193-200. New York: Springer-Verlag New York, Inc., 1991.
65. Scrocchi, L. A., and Jones, L. A. Alteration of proto-oncogene c-fos expression in neonatal estrogenized BALB/C female mice and murine cervicovaginal tumor LJ6195. Endocrinology, 129: 2251-2253, 1991.
66. Nephew, J. P., Peters, G. A., and Khan, S. A. Cellular localization of estradiol-induced c-fos messenger ribonucleic acid in the rat uterus: c-fos expression and uterine cell proliferation do not correlate strictly. Endocrinology, 136: 3007-3015, 1995.
67. Wosikowski, K., Eppenberger, U., Kung, W., Nagamine, Y., and Mueller, H. c-fos, c-jun, and c-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun., 188: 1067-1076, 1992.
68. Dubic, D., Dembinski, T. C., and Shiu, R. P. C. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells. Cancer Res., 47: 6517-6521, 1987.
69. Weisz, A., and Bresciani, F. Estrogen regulation of proto-oncogenes coding for nuclear proteins. Crit. Rev. Oncog., 4: 361-388, 1993.
70. Smeyne, R. J., Vendrell, M., Hayward, M., Baker, S. J., Miao, G. G., Schilling, K., Robertson, L. M., Curran, T., and Morgan, J. I. Continuous c-fos expression precedes programmed cell death in vivo. Nature (Lond.), 363: 166-169, 1993.
71. Studzinski, G. P., Brelvi, Z. S., Feldman, S. C., and Watt, R. A. Participation of c-myc protein in DNA synthesis of human cells. Science (Washington DC), 234: 467-470, 1986.
72. Amati, B., Littlewood, T. D., Evan, G. I., and Land, H. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J., 12: 5083-5087, 1993.
73. Bello-Fernandez, C., Packham, G., and Cleveland, J. L. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA, 90: 7804-7809, 1993.
74. Bowlin, T. L., McKnown, B. J., and Sunkara, P. S. Ornithine decarboxylase induction and polyamine biosynthesis are required for the growth of interleukin-2-and interleukin-3-dependent cell lines. Cell. Immunol., 98: 341-350, 1986.
75. Heikkila, R., Schwab, G., Wickstrom, E., Lohie, S. L., Pliznik, D. H., Watt, R., and Nacres, L. M. A c-myc antisense oligonucleotide inhibits entry into S phase but not progression from G0 to G1. Nature (Lond.), 328: 445-449, 1987.
76. Eilers, M., Dicard, P., Yamamoto, K. R., and Bishop, J. M. Chimaeras of Myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (Lond.), 340: 66-68, 1989.
77. Auvinen, M., Paasinen, A., Andersson, L. C., and Holtta, E. Ornithine decarboxylase activity is critical for cell transformation. Nature (Lond.), 360: 355-358, 1992.
78. Sawyers, C. L., Callahan, W., and Witte, O. N. Dominant negative Myc blocks transformation by Abl oncogenes. Cell, 70: 901-910, 1992.
79. Korach, K., Fox-Davies, C., and Baker, V. Differential response to estriol and estradiol in the mouse uterus: correlation to an additional nuclear event. Endocrinology, 106: 1900-1906, 1980.
80. Olson, M. E., Sheehan, D. M., and Branham, W. S. The postnatal ontogeny of rat uterine ornithine decarboxylase: acquisition of a second peak of estrogen-induced enzyme activity. Endocrinology, 113: 1826-1831, 1983.
81. Packham, G., and Cleveland, J. Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol. Cell. Biol., 14: 5741-5747, 1994.
82. Desiderio, M. A., Grassili, E., Bellesia, E., Salomoni, P., and Franceschi, C. Involvement of ornithine decarboxylase and polyamines in glucocorticoid-induced apoptosis of rat thymocytes. Cell Growth & Differ., 6: 505-513, 1995.
83. Tobias, K. E., and Kahana, C. Exposure to ornithine results in excessive accumulation of putrescine and apoptotic cell death in ornithine decarboxylase overproducing mouse myeloma cells. Cell Growth & Differ., 6: 1279-1285, 1995.
84. Fanidi, A., Harrington, E. A., and Evan, G. I. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (Lond.), 359: 554-556, 1992.
85. Barinaga, M. Cell suicide: by ICE, not fire. Science (Washington DC), 263: 754-756, 1994.
86. Wyllie, A. H. Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev., 11: 95-103, 1992.
87. Kerr, J. F., Winterford, C. M., and Harmon, B. V. Apoptosis: its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1993.
88. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science (Washington DC), 267: 1456-1462, 1995.
89. Hendry, W. J., and Leavitt, W. W. Binding and retention of estrogen in the uterus of hamsters treated neonatally with diethylstilbestrol. J. Steroid Biochem., 17: 479-487, 1982.
90. Hendry, W. J., Branham, W. S., and Sheehan, D. M. The hamster cheek pouch as a convenient ectopic site for studies of uterine morphogenesis and endocrine responsiveness. Differentiation, 51: 49-54, 1992.
91. Noonberg, S. B., Scott, G. K., Hunt, C. A., and Benz, C. C. Highly sensitive northern hybridization of rare mRNA using a positively charged nylon membrane. BioTechniques, 16: 1075-1078, 1994.
92. Kawai, K., Serizawa, A., Hamana, T., and Tsutsumi, Y. Heat-induced antigen retrieval of proliferating cell nuclear antigen and p53 protein in formalin-fixed paraffin-embedded sections. Pathol. Int., 44: 759-764, 1994.
93. Tron, V. A., Krajewski, S., Klein-Parker, H., Li, G., Ho, V. C., and Reed, J. C. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am. J. Pathol., 146: 643-650, 1995.
94. Zheng, X., Geiger, M., Ecke, S., Bielek, E., Donner, P., Eberspaecher, U., Schleuning, W-D., and Binder, B. R. Inhibition of acrosin by protein C inhibitor and localization of protein C inhibitor to spermatozoa. Am. J. Physiol., 267: C466-C472, 1994.